TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A perspective published in Frontiers in Psychiatry on Dec. 10, 2025, argues that delayed circadian timing is a common, clinically relevant pattern for a subgroup of people with ADHD. It reviews evidence that light and melatonin can shift circadian phase, but says more rigorous studies are needed to determine who benefits and whether these changes improve core ADHD symptoms.
A perspective article published Dec. 10, 2025, argues that circadian rhythm disruption is a common and clinically relevant pattern in a substantial subgroup of people with ADHD, and proposes screening and behavioral interventions as additions to care. The authors cite evidence of later sleep timing and delayed biological markers, while stressing that the approach needs better, stratified clinical trials and should not be taken to mean ADHD is itself a circadian disorder in every person.
The article, published in Frontiers in Psychiatry, brings together findings on sleep, chronotype and biological rhythms in children and adults with ADHD. It reports that sleep disturbances affect up to 80% of adults and 82% of children with ADHD in cited studies, and that delayed sleep-wake timing has been reported in up to 78%. These are estimates from prior research summarized by the authors, not results from a new population study.
Among the biological measures discussed, dim-light melatonin onset (DLMO)—a marker of circadian phase—has been reported as delayed by about 45 minutes in children and 90 minutes in adults with ADHD. The perspective also describes findings involving delayed or blunted cortisol rhythms, smaller pineal gland volume, and altered rhythms in peripheral clock genes. The authors note that ADHD and sleep problems can interact in complex, bidirectional ways; the reported associations do not establish that circadian delay causes ADHD.
The authors review intervention research in which melatonin and bright light advanced DLMO in ADHD groups. Some emerging findings link phase advancement with symptom improvement, and the article reports that circadian preference shifts predicted improvement in winter trials. It also discusses sleep programs for children that improved sleep and functioning alongside ADHD symptoms. These findings vary by study and do not establish a single effective protocol for all patients.
How Clock Timing Could Shape ADHD Care
If delayed circadian timing contributes to sleep difficulty or daytime functioning for some people with ADHD, identifying that pattern could help clinicians tailor support rather than treating sleep as a separate afterthought. The article proposes a behavioral-first adjunct: regular wake times, morning bright light, reduced evening light and screen exposure, and consistent daily timing cues. It also suggests considering low-dose melatonin selectively when a delay is confirmed or considered likely.
The potential relevance is practical, but the evidence does not show that these measures replace established ADHD treatment or reliably reduce core symptoms across the population. The authors frame circadian interventions as additions to care, and call for studies that can identify likely responders, test protocols, and measure ADHD outcomes. Melatonin use and light interventions should be discussed with a qualified health professional, particularly for children or people taking other medication.
melatonin supplements for sleep delay
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Evidence Behind the Circadian Link
The article is a perspective, not a new clinical trial or formal treatment guideline. Its case rests on converging prior research: self-reported sleep problems, objective sleep measures, evening chronotype findings and biological markers such as melatonin onset. The authors say sleep difficulties remain associated with ADHD in studies controlling for anxiety and depression, while recognizing that sleep and ADHD symptoms may influence one another.
The perspective also points to possible interactions with treatment. It cites studies in which daytime melatonin levels in children changed with methylphenidate treatment, alongside evidence of shifts in melatonin timing. Such findings suggest that medication and circadian biology may intersect, but do not establish a medication effect that can be generalized to every patient. The proposed approach is to screen for sleep and circadian difficulties, characterize timing where feasible, and match interventions to the person’s pattern.
bright light therapy lamp for circadian rhythm
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Limits of the Current Evidence
The article synthesizes evidence but does not provide a new trial that can establish whether circadian disruption causes ADHD symptoms or how much clock-shifting interventions improve them. The prevalence figures and marker delays come from earlier studies with differing methods and populations; they should not be read as applying to every person with ADHD. It also remains unclear which phenotypes respond best, what intervention timing and duration are most effective, and how durable any gains are.
The authors describe some intervention results as emerging and call for well-designed, stratified trials. Evidence for exercise and combined protocols cited in the article includes work in non-ADHD populations, so their effects in ADHD remain to be tested. The perspective does not establish circadian treatment as a replacement for standard ADHD care.
As an affiliate, we earn on qualifying purchases.
Trials Needed to Test the Approach
The authors call for future studies that stratify participants by circadian profile, measure core ADHD outcomes, identify who responds, and optimize intervention protocols. In clinical settings, their proposed pathway begins with routine sleep screening, followed where appropriate by chronotype assessment, sleep tracking and DLMO measurement when available. They suggest testing regular wake times, morning light and evening light reduction, with selective melatonin for likely or confirmed delays.
No specific upcoming trial or implementation date is identified in the source material. Until stronger evidence is available, the central development is a research-backed proposal for circadian-aware, individualized adjuncts—not a change to established ADHD treatment guidance.
As an affiliate, we earn on qualifying purchases.
Key Questions
Does the article say ADHD is a circadian rhythm disorder?
No. The authors describe circadian disruption as a common phenotype in a substantial subgroup of people with ADHD, not as a feature of everyone with ADHD or a proven cause of the condition.
What does delayed DLMO mean?
Dim-light melatonin onset is a biological marker used to estimate circadian phase. The perspective reports delays of about 45 minutes in children and 90 minutes in adults with ADHD in cited studies; these are group-level findings, not an individual diagnosis.
Can light therapy or melatonin treat ADHD?
The article reviews studies in which bright light and melatonin advanced circadian timing, with emerging links between phase advancement and symptom improvement. It does not establish either as a standalone ADHD treatment or a universal recommendation. Discuss treatment decisions with a qualified health professional.
What interventions do the authors propose?
The proposed behavioral-first approach includes a fixed wake time, morning bright light, less evening light and screen exposure, and regular daily timing cues. The authors suggest selective low-dose melatonin when a circadian delay is confirmed or probable, while calling for further trials.
Source: hn
Cold & flu season Picks
humidifiers
As an affiliate, we earn on qualifying purchases.
